[ Arzeda raises $12M in Series A ]
Arzeda has raised $12 million in Series A funding.
Founded in 2008, Arzeda develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production.
The new investment will accelerate scale-up of Arzeda’s advanced protein design technology that can deliver revolutionary new production pathways for a wide range of valuable chemicals and materials, and serve more partners at greater scale.
|Founder / CEO||Alexandre Zanghellini|
|Conversion Ventures LLC|
|Previous Investors||WRF Capital|